Repaglinide and Nateglinide for Type 2 Diabetes
Medications that help the pancreas make more insulin
Repaglinide and nateglinide were developed in 1997. They’re often grouped together, even though they’re technically part of two different classes of medications. Repaglinide is a meglitinide, and nateglinide is a phenylalanine derivative.
How they work: Both repaglinide and nateglinide stimulate the beta cells to make more insulin, just like sulfonylureas. However, unlike sulfonylureas, they’re taken just before eating. They cause your pancreas to produce enough insulin for that meal.
Special notes: Since you’re taking these medications around the time you’re eating, you don’t have to stick to a regular meal schedule, as you do with a sulfonylurea. (Although, it is generally healthier if you maintain a regular, well-balanced meal schedule.) Take these medications only if you are eating a meal.
Examples of these medications:
- Prandin is the brand name for repaglinide.
- Starlix is the brand name for nateglinide.
- American Diabetes Association. Standards of Medical Care in Diabetes—2009. Diabetes Care. 2009;32:S13-61.
- Becker G. Type 2 Diabetes: An Essential Guide for the newly Diagnosed. 2nd ed. New York, NY: Marlowe & Company; 2007.
- McCulloch D. Patient information: Diabetes type 2: Overview. UpToDate Web site. January 30, 2009. Available at: http://www.uptodate.com/patients/content/topic.do?topicKey=~n0K0MIfI1iZs.&selectedTitle=5~150&source=search_result. Accessed April 20, 2009.
- McCulloch D. Patient information: Diabetes mellitus type 2: Overview. UpToDate Web site. December 4, 2008. Available at: http://www.uptodate.com/patients/content/topic.do?topicKey=~X0jjLnBn4._ko&selectedTitle=4~150&source=search_result. Accessed April 20, 2009.